Griffin Doubles Down on AbbVie | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded19 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20063574

Show notes

Billionaire Ken Griffin just piled into AbbVie with a 547% stake boost—betting big on its future. Why? Because AbbVie’s a Dividend King with relentless cash flow, widening margins, and a smart pipeline. They’re eyeing a $10B acquisition of Apogee Therapeutics to bring a revolutionary new drug for skin conditions—with a super-convenient dosing schedule. It’s the same playbook that worked when Humira’s patent expired: build on proven science, out-innovate the competition. Even with some debt, investors see long-term upside thanks to a juicy dividend yield and a track record of growth. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/5a81d5443e8728c7

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.